Marshall Wace »

Benitec Biopharma shares owned by Marshall Wace

Quarter-by-quarter ownership of Benitec Biopharma (BNTC) shares owned by Marshall Wace from 13F filings

Historical chart of Marshall Wace investment in Benitec Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Benitec Biopharma held by Marshall Wace consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Benitec Biopharma by Marshall Wace

Quarter filed Position value Share count Share price at filing
2025-12-31 $481k 36k 13.47
2025-06-30 $503k 43k 11.70

More positions owned by Marshall Wace

Ishares-s&p 500 Etp (IVV)
Vanguard S&p 500 Etp (VOO)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Eli Lilly & Co Common Stock (LLY)
Alphabet Inc-a Common Stock (GOOGL)
Broadcom Common Stock (AVGO)
Adv Micro Device Equity Option Call Option (AMD)
Meta Platforms-a Common Stock (META)
Walmart Common Stock (WMT)
Tesla Common Stock (TSLA)
Alphabet Inc-c Common Stock (GOOG)
Circle Internet Common Stock (CRCL)

View all positions for Marshall Wace

Top funds holding Benitec Biopharma

Suvretta Capital Management
Henderson Group
Franklin Resources
Adage Capital Partners GP
Vanguard Group
Nantahala Capital Management
BlackRock
Infinitum Asset Management
Siren
Alyeska Investment Group
Silverarc Capital Management
Geode Capital Management
AWM Investment Company
Schonfeld Strategic Advisors
State Street Corporation

View all funds holding Benitec Biopharma